Markets
Borrow
Earn
Invest
Private
Security
Newsroom
More
Log In
Sign Up
Markets
Market Overview
Indices and commodities.
Digital Credit
Bitcoin treasury preferreds.
AI Stocks
The artificial intelligence theme.
Bitcoin Treasuries
Companies holding bitcoin.
Economy
Sectors, global markets and rates.
Popular Portfolios
13F filings, smart money.
Borrow
Borrow
Borrow USDT or USDC against your BTC without giving it up.
ReFi
Switch your bitcoin-backed loan and pay less interest.
Earn
Carry Trade
Borrow, invest, keep the spread.
Stock Dividends
Dividends from tokenized equities.
Invest
Private
Security
Newsroom
More
Company
About Us
Our leadership team, mission, and investors.
Whitepaper
Vision, purpose, and architecture behind Roxom.
Legal
Terms, privacy, and disclosures.
Resources
Help Center
Guides, FAQs & support.
Rulebook
Trading logic, platform rules, and fundamentals.
API Docs
Connect, authenticate, and build with our API.
Status
Current platform health and incidents.
Chart
Financials
Earnings
News
About
Dividends
Insider
Filings
BTC
SATS
USD
1d
1w
1m
6m
YTD
1y
5y
All
Loading chart
1 BTC
=
- USD
BTC
SATS
Loading market data...
Chart
Financials
Earnings
News
About
Dividends
Insider
Filings
BTC
SATS
USD
1d
1w
1m
6m
YTD
1y
5y
All
Loading chart
TH
Tenet Healthcare Corporation New
THC
Mkt Cap
$21.50B
Volume
666.04K
Next Earnings
October 29th
Chart
Financials
Earnings
News
About
Dividends
Insider
Filings
BTC
SATS
USD
1d
1w
1m
6m
YTD
1y
5y
All
Loading chart
TH
THC
TH
Tenet Healthcare Corporation New
THC
News
·
Why Tenet Healthcare (THC) is a Top Growth Stock for the Long-Term
Mkt Cap
$21.52B
Volume
666.04K
Next Earnings
October 29th
Chart
Financials
Earnings
News
About
Insider
Filings
Why Tenet Healthcare (THC) is a Top Growth Stock for the Long-Term
Tenet Healthcare (THC) is featured as a stock to watch with a #3 (Hold) Zacks Rank and an A-rated VGM Score. The company demonstrates strong growth potential with a Growth Style Score of B and forecasted year-over-year earnings growth of 25.4% for the current fiscal year. One analyst revised earnings estimates upward in the last 60 days, with the Zacks Consensus Estimate increasing to $21.04 per share.
Zacks Investment Research · Oct 16, 2026
Why Tenet Healthcare (THC) Outpaced the Stock Market Today
Tenet Healthcare (THC) closed at $275.13, up 1.3%, outperforming the S&P 500's 0.33% gain. The hospital operator is expected to report Q3 2026 earnings of $4.59 per share (up 24.05% YoY) with revenue of $5.47 billion (up 3.4% YoY). Full-year estimates project $21.04 EPS and $22.2 billion revenue. THC holds a Zacks Rank #3 (Hold) with a Forward P/E of 12.91, trading in line with its industry average. The Medical-Hospital industry ranks 195th out of 250+ industries.
Zacks Investment Research · Oct 15, 2026
Tenet Healthcare (THC) Beats Stock Market Upswing: What Investors Need to Know
Tenet Healthcare closed at $263.78, up 1.23% and outpacing the S&P 500's 0.6% gain. The hospital operator is expected to report Q3 EPS of $4.59 (up 24.05% YoY) and revenue of $5.47 billion (up 3.4% YoY) on October 29, 2026. With a Zacks Rank of #3 (Hold) and Forward P/E of 12.39, THC trades in line with its industry average valuation.
Zacks Investment Research · Oct 9, 2026
Why Tenet Healthcare (THC) is a Top Value Stock for the Long-Term
Tenet Healthcare (THC) receives a #3 (Hold) rating on the Zacks Rank with a VGM Score of B. The company benefits from attractive valuation metrics including a forward P/E ratio of 12.35 and a Value Style Score of A. Two analysts revised earnings estimates upward in the last 60 days, with the Zacks Consensus Estimate increasing $0.75 to $21.04 per share, and the company maintains an average earnings surprise of +22.7%.
Zacks Investment Research · Oct 8, 2026
Tenet Healthcare Corporation (THC) is Attracting Investor Attention: Here is What You Should Know
Tenet Healthcare (THC) is receiving increased investor attention. The stock has underperformed the S&P 500 over the past month (-3.4% vs +1.4%). While the company beat earnings and revenue estimates in recent quarters with strong EPS growth of +25.4% expected for the current fiscal year, the Zacks Rank #3 (Hold) rating suggests the stock may perform in line with the broader market in the near term. The company trades at a valuation discount to peers.
Zacks Investment Research · Oct 8, 2026
Tenet Healthcare (THC) Outpaces Stock Market Gains: What You Should Know
Tenet Healthcare stock rose 1.83% to $258.62, outperforming the S&P 500's 0.73% gain. The hospital operator is projected to report Q3 EPS of $4.59 (up 24.05% YoY) and revenue of $5.47 billion (up 3.4% YoY). For the full year, earnings are forecast at $21.04 per share and revenue at $22.2 billion. THC holds a Zacks Rank #3 (Hold) with a Forward P/E of 12.07 and PEG ratio of 0.97.
Zacks Investment Research · Oct 2, 2026
Can THC's Cash Flow Support Its Expanding Capital-Return Strategy?
Tenet Healthcare (THC) is accelerating share buybacks and raising 2026 free cash flow guidance to $1.825-$2.055 billion, supported by 27.1% year-over-year growth in operating cash flow to $2.2 billion. The company has $2.1 billion remaining in buyback authorization while continuing to invest in growth initiatives and managing debt obligations.
Zacks Investment Research · Sep 30, 2026
Here's Why Tenet Healthcare (THC) is a Strong Growth Stock
Tenet Healthcare (THC) is featured as a stock to watch with a #3 (Hold) Zacks Rank and an A VGM Score. The company shows strong growth prospects with forecasted year-over-year earnings growth of 25.4% for the current fiscal year, supported by three upward earnings estimate revisions in the last 60 days and an average earnings surprise of +22.7%.
Zacks Investment Research · Sep 30, 2026
Can Pediatrix Sustain Growth Despite Lower Patient Volumes?
Pediatrix Medical Group (MD) reported 4% YoY revenue growth to $487.8 million in Q2 2026, driven by improved reimbursement and higher patient acuity, offsetting a 2.1% decline in patient volumes. The company reaffirmed its 2026 adjusted EBITDA guidance of $280-$300 million, though volume trends and easing collection benefits remain key risks.
Zacks Investment Research · Sep 22, 2026
Tenet Healthcare Director Nadja West Sells 1,152 Shares
Tenet Healthcare Director Nadja West sold 1,152 shares (5% of her direct holdings) on September 2, 2026, for approximately $298,138 at $258.80 per share. West retained 23,653 shares valued at $6.1 million, indicating continued confidence in the company. Analysts view the sale as routine profit-taking following strong 39% one-year stock performance.
The Motley Fool · Sep 20, 2026
Holdings
Open Orders (0)
Positions (0)
Order History
Dividends
Transfers
Log In
to start trading
TH
THC
Tenet Healthcare Corporation New
Buy
Sell
Market
Limit
Soon
THC
25%
50%
75%
Max
Pay with
—
Start Trading
Available Balance
0.00
Your Position
You don't own any THC yet.
Related Tickers
HC
HCA
—
AC
ACHC
—
CY
CYH
—
EH
EHC
—
UH
UHS
—
Earnings